A webcast of the presentation will be accessible by visiting the Presentation & Events section on the “Investors” page of Aligos’ website at www.aligos.com. A replay of the webcast will be available ...
New Jersey City University (NJCU) will host its in-person Fall 2025 Open House on Saturday, October 18, 2025, from 9 a.m. to ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
With a narrow vote, Bonita Springs city council advanced petitions for land use amendments for a mixed-use community known as ...
Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The ...
Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today announced that it will present new clinical data from its Phase 2 trial of EB613 at ...
2d
I-Mab (IMAB) Discusses Business Transformation Strategy and Plans for Accelerated Growth Transcript
Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...
“Katina brings to Prelude an abundance of experience as a strategic and financial advisor to our leadership team,” stated Kris Vaddi, Ph.D., Chief Executive Officer of Prelude. “We welcome her to our ...
The News Tribune reached out to the four candidates to hear their views on the principal shake-up, as well as how they’d ...
"The last two years of uncertainty have created anxiety and frustration and division," said Sunderland resident Leslie Carr. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback